United Therapeutics is the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs.
United Therapeutics seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter's pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
The Senior/Health Policy and Pipeline Strategy Manager will serve as our internal and external subject matter expert for Health Policy related matters. Health Policy employee will assist the Director in developing and implementing strategies for Health Policy programs. This role will also support all commercially available products and align pipeline products in development with United Therapeutics commercial business objectives.
Track key federal policy, legislative, and regulatory developments affecting the Company's product portfolio and communicate analysis and anticipated or potential impacts with Senior Leadership. Develop relationships with key government agencies (e.g. HHS, CMS, CMMI, HRSA) and policy contacts to advocate for issues or positions important to the Company. Proactively communicate on federal policy issues, including legislation, proposed rules, and agency guidance that may impact the Company's business activities or products. Analyze HHS-related proposed and final rules or other guidance and communicate implications to internal stakeholders to identify potential business impacts. Collaborate with Patient Advocacy and Corporate Communications to develop programs and materials that educate on policy issues affecting the Company's patients. Provide insights to internal stakeholders on emerging policy proposals that support strategic planning and financial modeling. Conduct initial analyses of health policy proposals and identify issues influencing the Company's ability to operate effectively as an innovative company. Maintain broad understanding of the drug approval and coverage process and working knowledge of healthcare policy related to reimbursement decision-making for drugs and biologics. Attend policy and trade conferences, BIO meetings, and health policy panels and share insights with internal stakeholders on issues impacting the Company. Work with internal stakeholders to develop strategic policy positions supporting the Company's pipeline and marketed products. Collaborate with government affairs team members and consultants to set policy objectives. Support reimbursement activities for UT products related to coding, coverage, and payment as requested.
Minimum Requirements:
Preferred Qualifications:
Location: United Therapeutics has the flexibility to hire this role remotely with ideal candidates residing in the DC Metro area.